Healthy Skepticism International News
May 2003
Portal to BMJ Special issue on Doctors and the Drug industry
We invite subscribers to read and write rapid responses to one or more of the articles below.
The links below will open BMJ articles in a new window.
Editor’s choice
Food, flattery, and friendship
Jane Smith [Full text] [PDF]
This week in the BMJ
This week in the BMJ [Full text] [PDF]
Research sponsored by drug companies is biased [Full text]
Drug representatives may increase unnecessary GP prescribing [Full text]
Reporting of clinical trials of drugs shows bias [Full text]
Editorials
No more free lunches
Kamran Abbasi and Richard Smith
BMJ 2003; 326: 1155-1156. [Full text] [PDF]
Information from drug companies and opinion leaders
Alessandro Liberati and Nicola Magrini
BMJ 2003; 326: 1156-1157. [Full text] [PDF]
News
Drug company secretly briefed medical societies on HRT [Full text] [PDF]
Schering uses German medical association to promote HRT [Full text] [PDF]
Drug company sponsorship of education could be replaced at a fraction of its cost [Full text] [PDF]
Drug companies advised to publish unfavourable trial results [Full text] [PDF]
News roundup
World body reviews doctors’ links to drug industry [Abridged text] [Abridged PDF] [Full text]
Papers
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
Joel Lexchin, Lisa A Bero, Benjamin Djulbegovic, and Otavio Clark
BMJ 2003; 326: 1167-1170. [Abstract] [Abridged text] [Abridged PDF] [Full text] [PDF]
Evidence b(i)ased medicine-selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications
Hans Melander, Jane Ahlqvist-Rastad, Gertie Meijer, and Björn Beermann
BMJ 2003; 326: 1171-1173. [Abstract] [Abridged text] [Abridged PDF] [Full text] [PDF]
Primary care
Characteristics of general practitioners who frequently see drug industry representatives: national cross sectional study
Chris Watkins, Laurence Moore, Ian Harvey, Patricia Carthy, Elizabeth Robinson, and Richard Brawn
BMJ 2003; 326: 1178-1179. [Full text] [PDF]
Education and debate
Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: Entanglement
Ray Moynihan
BMJ 2003; 326: 1189-1192. [Full text] [PDF]
Who pays for the pizza? Redefining the relationships between doctors and drug companies. 2: Disentanglement
Ray Moynihan
BMJ 2003; 326: 1193-1196. [Full text] [PDF]
How to dance with porcupines: rules and guidelines on doctors’ relations with drug companies
Elizabeth Wager
BMJ 2003; 326: 1196-1198. [Full text] [PDF]
Medical journals and pharmaceutical companies: uneasy bedfellows
Richard Smith
BMJ 2003; 326: 1202-1205. [Full text] [PDF]
Unhealthy spin
Bob Burton and Andy Rowell
BMJ 2003; 326: 1205-1207. [Full text] [PDF]
Relationships between the pharmaceutical industry and patients’ organisations
Andrew Herxheimer
BMJ 2003; 326: 1208-1210. [Full text] [PDF]
Letters
Journals should select drug advertisements more carefully
James J Oliver and Simon R Maxwell
BMJ 2003; 326: 1211. [Full text]
Charities and patient groups should declare interests
Jenny Hirst
BMJ 2003; 326: 1211. [Full text]
reviews
Multimedia
Book: The Big Fix: How the Pharmaceutical Industry Rips Off American Consumers
Ray Moynihan [Full text] [PDF]
Ad: Regulator spells out rules on disease awareness campaigns
Trevor Jackson [Full text]
Website Of The Week: Doctors and the drug industry
Marcus Müllner [Full text]
Personal views
In praise of the “devil”
Silvia Bonaccorso and Richard Smith [Full text]
How not to do medical research
Philip Belcher [Full text]
Page views since 15 March 2010: 5722
Comments
Our members can see and make comments on this page.
